BiotechTube
Innova Vascular

Innova Vascular

Carlsbad, United States· Est.
innovavascular.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $18M

Overview

Innova Vascular is a clinical-stage medical device company focused on thrombectomy solutions for vascular disease. Founded in 2017, the company has achieved key regulatory milestones, including FDA clearance for its Laguna Thrombectomy System in 2023 and early commercial use in 2024. Led by an experienced founder with a strong track record in device development and commercialization, Innova is positioned to address the significant market for minimally invasive treatment of pulmonary embolism and peripheral vascular clots.

CardiovascularVascular Disease

Technology Platform

Minimally invasive mechanical thrombectomy platform combining clot retrieval and aspiration for treating vascular thromboembolism in the peripheral vasculature, with development for pulmonary embolism.

Funding History

2
Total raised:$18M
Series A$15M
Seed$3M

Opportunities

The massive and growing pulmonary embolism treatment market represents a multi-billion dollar opportunity, where a successful clinical study could position Innova for a high-value exit or partnership.
The initial clearance in the peripheral vasculature provides a foundation for early revenue and clinical proof-of-concept while the PE program advances.

Risk Factors

Intense competition from large, well-funded public medtech companies in the thrombectomy space poses a major commercial threat.
The company's financial runway and ability to fund an expensive pivotal trial for pulmonary embolism while scaling commercial operations is a key dependency and risk.

Competitive Landscape

Innova operates in the highly competitive thrombectomy device market, facing off against giants like Boston Scientific, Johnson & Johnson, and Penumbra, as well as focused players like Inari Medical. Success will require demonstrating clear clinical or usability advantages to displace established products and secure hospital contracts.

More companies in Drug Delivery & Formulation →More companies in United States →